News & Events

Recent NewsView All News

Dec 16, 2025 4:05pm EST

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy

Dec 5, 2025 6:15am EST

Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock

View All News

Recent Events View All Events

Dec 17, 2025 1:00 pm EST

Capricor Therapeutics and PPMD Webinar: HOPE-3 Community Update

Dec 3, 2025 8:00 am EST

Capricor Therapeutics Hope 3 Top Line Data Call

View All Events

Latest Presentation View All Presentations

Oct 13, 2025

Investor Presentation - October 2025

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up